Secondary mutations in other genes (paired box 5/PAX5, cyclin-dependent kinase inhibitor 2A/CDKN2A, etc.)are postulated to be requisite for the full development of leukemia, and together they accelerate the onset and progression of leukemia.52 Here, CDKN2A is linked to leukemia.